Recent Finacing
Recent Raise
Goldfinch Bio uses genomics-driven precision medicine and a Kidney Genome Atlas to discover kidney disease drug targets, develop biomarkers, assemble genomic/phenotypic patient registries, and advance targeted therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Goldfinch Biopharma.
